筛选条件 共查询到174条结果
排序方式
Recent developments of human monocarboxylate transporter (hMCT) inhibitors as anticancer agents

期刊: DRUG DISCOVERY TODAY, 2021; 26 (3)

Cancer cells metabolize glucose via anaerobic glycolysis, with lactate formed in the cytosol as the end-product. To avoid intercellular acidification,......

Solute carriers as potential oncodrivers or suppressors: their key functions in malignant tumor formation

期刊: DRUG DISCOVERY TODAY, 2021; 26 (7)

Solute carrier (SLC) transporters are primarily known for their function in the transportation of various exogenous/endogenous substances via influx/e......

The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer

期刊: DRUG DISCOVERY TODAY, 2021; 26 (7)

Triple-negative breast cancers (TNBCs) form a heterogeneous group of breast carcinomas that lack expression of estrogen receptor, progesterone recepto......

New views on endothelial dysfunction in gestational hypertension and potential therapy targets

期刊: DRUG DISCOVERY TODAY, 2021; 26 (6)

The placenta has vital roles in metabolite exchange, fetal growth, and preeclampsia (PE). In this review, we discuss the pathogenesis of hypertension ......

Targeting reactive oxygen species in stem cells for bone therapy

期刊: DRUG DISCOVERY TODAY, 2021; 26 (5)

Reactive oxygen species (ROS) have emerged as key players in regulating the fate and function of stem cells from both non-hematopoietic and hematopoie......

Construction of cancer-on-a-chip for drug screening

期刊: DRUG DISCOVERY TODAY, 2021; 26 (8)

Cancer-on-a-chip has recently emerged and attracted wide attention in the field of anticancer drug screening. Compared with traditional cancer models,......

Inhibiting ferroptosis: A novel approach for stroke therapeutics

期刊: DRUG DISCOVERY TODAY, 2021; 26 (4)

Stroke ranks as the second leading cause of death across the globe. Despite advances in stroke therapeutics, no US Food and Drug Administration (FDA)-......

Benchmarking the mechanisms of frequent hitters: limitation of PAINS alerts

期刊: DRUG DISCOVERY TODAY, 2021; 26 (6)

In 2010, the pan-assay interference compounds (PAINS) rule was proposed to identify false-positive compounds, especially frequent hitters (FHs), in bi......

Graph neural networks for automated de novo drug design

期刊: DRUG DISCOVERY TODAY, 2021; 26 (6)

The goal of de novo drug design is to create novel chemical entities with desired biological activities and pharmacokinetics (PK) properties. Over rec......

Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases

期刊: DRUG DISCOVERY TODAY, 2021; 26 (6)

Innate immunity serves as a first line of defence against danger signals, invading pathogens and microbes. The inflammasomes, as pattern recognition r......

Gene therapy in solid tumors: trends in trials in China and beyond

期刊: DRUG DISCOVERY TODAY, 2021; 26 (2)

Gene therapy involves the introduction of new genes into cells, to modify or manipulate the expression of a gene or to alter the biological properties......

Strategies for maximizing photothermal conversion efficiency based on organic dyes

期刊: DRUG DISCOVERY TODAY, 2021; 26 (8)

Photothermal therapy (PTT) has emerged as a promising therapeutic approach for tumor control and ablation. Attention has focused on exploring advanced......

Development of inhibitors for uPAR: blocking the interaction of uPAR with its partners

期刊: DRUG DISCOVERY TODAY, 2021; 26 (4)

Urokinase-type plasminogen activator receptor (uPAR) mediates a multitude of biological activities, has key roles in several clinical indications, inc......

Human ClpP protease, a promising therapy target for diseases of mitochondrial dysfunction

期刊: DRUG DISCOVERY TODAY, 2021; 26 (4)

Human caseinolytic protease P (HsClpP), an ATP-dependent unfolding peptidase protein in the mitochondrial matrix, controls protein quality, regulates ......

Autophagy-regulating miRNAs: potential targets for obesity and related metabolic disorders

期刊: DRUG DISCOVERY TODAY, 2021; 26 (6)

Obesity is positively correlated with a variety of metabolic disorders. Autophagy is the major recycling process in adipocytes, dynamically regulating......

共174条页码: 1/12页15条/页